Interaction Between Ginkgolic Acid and Human Serum Albumin by Spectroscopy and Molecular Modeling Methods

被引:11
作者
Zhu, Guo-fei [1 ]
Wang, Yu [1 ]
Liu, Jin [1 ]
Wang, Hao [1 ]
Xi, Lei [1 ]
Du, Lin-fang [1 ]
机构
[1] Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu 610064, Peoples R China
关键词
Human serum albumin; Ginkgolic acid; FT-IR; Fluorescence spectroscopy; Molecular docking; SECONDARY STRUCTURE; BINDING; STABILITY; DRUG; CONFORMATION; PLASMA;
D O I
10.1007/s10953-014-0200-5
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
The interaction of ginkgolic acid (15:1, GA) with human serum albumin (HSA) was investigated by FT-IR, CD and fluorescence spectroscopic methods as well as molecular modeling. FT-IR and CD spectroscopic showed that complexation with the drug alters the protein's conformation by a major reduction of alpha-helix from 54 % (free HSA) to 46-31 % (drug-complex), inducing a partial protein destabilization. Fluorescence emission spectra demonstrated that the fluorescence quenching of HSA by GA was by a static quenching process with binding constants on the order of 10(5) L center dot mol(-1). The thermodynamic parameters (Delta H = -28.26 kJ center dot mol(-1), Delta S = 11.55 J center dot mol(-1)center dot K-1) indicate that hydrophobic forces play a leading role in the formation of the GA-HSA complex. The ratio of GA and HSA in the complex is 1:1 and the binding distance between them was calculated as 2.2 nm based on the Forster theory, which indicates that the energy transfer from the tryptophan residue in HSA to GA occurs with high probability. On the other hand, molecular docking studies reveal that GA binds to Site II of HSA (sub-domain IIIA), and it also shows that several amino acids participate in drug-protein complexation, which is stabilized by H-bonding.
引用
收藏
页码:1232 / 1249
页数:18
相关论文
共 53 条
  • [1] Probing the Binding Sites of Antibiotic Drugs Doxorubicin and N-(trifluoroacetyl) Doxorubicin with Human and Bovine Serum Albumins
    Agudelo, Daniel
    Bourassa, Philippe
    Bruneau, Julie
    Berube, Gervais
    Asselin, Eric
    Tajmir-Riahi, Heidar-Ali
    [J]. PLOS ONE, 2012, 7 (08):
  • [2] The effects of drug complexation on the stability and conformation of human serum albumin
    Ahmed-Ouameur, A.
    Diamantoglou, S.
    Sedaghat-Herati, M. R.
    Nafisi, Sh.
    Carpentier, R.
    Tajmir-Riahi, H. A.
    [J]. CELL BIOCHEMISTRY AND BIOPHYSICS, 2006, 45 (02) : 203 - 213
  • [3] Strategy to tether organometallic ruthenium-arene anticancer compounds to recombinant human serum albumin
    Ang, Wee Han
    Daldini, Elisa
    Juillerat-Jeanneret, Lucienne
    Dyson, Paul J.
    [J]. INORGANIC CHEMISTRY, 2007, 46 (22) : 9048 - 9050
  • [4] [Anonymous], 1996, MODERN QUANTUM CHEM
  • [5] [Anonymous], 1996, ALL ALBUMIN BIOCH GE, DOI DOI 10.1016/B978-0-12-552110-9.X5000-4
  • [6] Polyamine analogues bind human serum albumin
    Beauchemin, R.
    N'soukpoe-Kossi, C. N.
    Thomas, T. J.
    Thomas, T.
    Carpentier, R.
    Tajmir-Riahi, H. A.
    [J]. BIOMACROMOLECULES, 2007, 8 (10) : 3177 - 3183
  • [7] Binding of several anti-tumor drugs to bovine serum albumin: Fluorescence study
    Bi, Shuyun
    Sun, Yantao
    Qiao, Chunyu
    Zhang, Hanqi
    Liu, Chunming
    [J]. JOURNAL OF LUMINESCENCE, 2009, 129 (05) : 541 - 547
  • [8] EXAMINATION OF THE SECONDARY STRUCTURE OF PROTEINS BY DECONVOLVED FTIR SPECTRA
    BYLER, DM
    SUSI, H
    [J]. BIOPOLYMERS, 1986, 25 (03) : 469 - 487
  • [9] CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153
  • [10] 3-DIMENSIONAL STRUCTURE OF HUMAN-SERUM ALBUMIN
    CARTER, DC
    HE, XM
    MUNSON, SH
    TWIGG, PD
    GERNERT, KM
    BROOM, MB
    MILLER, TY
    [J]. SCIENCE, 1989, 244 (4909) : 1195 - 1198